Previous Close | ¥1,465.50 |
Intrinsic Value | ¥242.84 |
Upside potential | -83% |
Data is not available at this time.
Lion Corporation operates as a diversified consumer goods company with a strong presence in Japan and select international markets. Its core segments—Consumer Products, Industrial Products, and Overseas Business—span oral care, personal hygiene, household cleaners, and specialty chemicals. The company leverages its century-old heritage to maintain brand trust, particularly in dental care, where it holds a competitive edge through innovation in formulations like periodontitis treatments. Its industrial division supplies niche chemicals for construction and manufacturing, adding stability to revenue streams. Lion’s vertically integrated production and distribution network enhances cost efficiency, while its focus on health-centric products aligns with Japan’s aging demographics and global wellness trends. Despite competition from multinationals like P&G and Unilever, Lion’s regional expertise and product localization sustain its market share.
Lion reported revenue of ¥412.9 billion for FY2024, with net income of ¥21.2 billion, reflecting a 5.1% net margin. Operating cash flow stood at ¥43.7 billion, though capital expenditures of ¥18.1 billion indicate ongoing investments in production capacity. The company’s asset-light model and focus on high-margin segments like oral care contribute to steady profitability.
Diluted EPS of ¥76.41 underscores Lion’s earnings stability, supported by recurring demand for essential consumer goods. The firm’s capital efficiency is evident in its low debt-to-equity ratio and disciplined reinvestment strategy, prioritizing R&D (e.g., dermatologic agents) and market expansion in Asia.
Lion maintains a robust balance sheet with ¥102.2 billion in cash and equivalents against ¥29.7 billion in total debt, ensuring liquidity. Its conservative leverage profile and strong cash reserves provide flexibility for strategic acquisitions or dividend growth.
Revenue growth has been modest, in line with Japan’s stagnant consumer market, but overseas expansion (e.g., health supplements in Southeast Asia) offers upside. The dividend payout of ¥27 per share reflects a sustainable ~35% payout ratio, appealing to income-focused investors.
At a market cap of ¥427.2 billion, Lion trades at ~20x trailing earnings, a premium to peers, likely pricing in its defensive qualities and brand equity. Low beta (0.002) signals resilience to market volatility.
Lion’s dual focus on consumer staples and industrial chemicals mitigates cyclical risks. Near-term challenges include input cost inflation, but its R&D pipeline (e.g., plant-based insulating oils) and aging-population tailwinds support long-term relevance.
Company filings, Bloomberg
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |